Contact Us

Gliese 623B


Gliese 623B, founded by Anthony Ball, provides consultant services in the areas of preclinical medical device validation in support of FDA  premarket notifications. We also provide antimicrobial discovery solutions, small molecule manufacturing support, study design and protocol development. Preclinical method validation, SOP authorship, risk assessments, laboratory management and construction services, and market assessment products is also offered.

Gliese 623B has been in operation since 2014, operating several research laboratories in the state of Massachusetts, and having raised over 21 million USD in public and private capital has established three spin-out medtech companies in addition to the aforementioned consulting services.

Interested in a proven model for commercializing your science?